Product Images Lamotrigine

Lamotrigine Extended-Release Tablets USP 250 mg is a medication prescribed for the treatment of seizures in patients suffering from epilepsy. This medication comes in a tablet form, and each tablet contains 250 mg of the active ingredient. The extended-release tablets are designed to release the medication slowly in the body, which helps to maintain a steady level of medicine in the blood and reduces the risk of side effects. Note that the text contains some errors and non-English characters.*

Dr. Reddy's Laboratories Limited is a pharmaceutical company that produces Lamotrigine Extended-Release tablets with a strength of 300 mg. Unfortunately, the rest of the text is not available as it seems to have been incorrectly recognized by the software.*

This appears to be a graph depicting the responder rates, improvement, and worsening of patients taking placebo and Lametrigine ER Tablets. The percentages displayed on the Y-axis range from -100% to 75%, while the X-axis shows the different categories of responders, improved patients, and worsened patients. The numbers in the graph represent the percentage of patients falling under each category.*

This is a list of different medication options with varying dosages, colors, and imprints for identification. The medications come in tablet and capsule form, and are imprinted with different codes for easy identification by medical professionals.*